Patients Decision Making in Choosing Between Colonic Investigation Alternatives

May 6, 2026 updated by: University of Aberdeen
This is a qualitative interview study to understand patients' priorities for different aspects of tests when considering a colonic investigation. Patients currently waiting for colon capsule endoscopy (CCE), and colonoscopy will be invited to take part. Semi-structured interviews will be carried out over the telephone following an interview guide. Recorded interviews will be transcribed and undergo thematic analysis. We will seek to publish the results of this study to inform future research and developments for colonic investigations.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

12

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United Kingdom
    • Scotland
      • Aberdeen, Scotland, United Kingdom
        • University of Aberdeen

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

This study will involve recruiting patients on the waiting list for colonoscopy or colon capsule endoscopy from one NHS Scotland Health Board.

Description

Inclusion Criteria:

  • Patients over 18 who are on the waiting list for a colonoscopy or CCE. Only patients who can provide valid consent will be included.
  • English language speaking (translation services are not available for this study).

Exclusion Criteria:

  • Patients undergoing colonoscopy due to positive bowel screening test or due to surveillance of known colonic pathology.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Colonoscopy
Patients awaiting colonoscopy
Behavioral: Interview
Semi structured patient interview via telephone
CCE
Patients awaiting colon capsule endoscopy
Behavioral: Interview
Semi structured patient interview via telephone

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Completion of a qualitative interview discussing the patients priorities for different aspects of tests when considering a colonic investigation
Time Frame: Through study completion, an average of 6 months
We will invite patients to undergo qualitative telephone interviews to establish their priorities for different aspects of tests when considering a colonic investigation.
Through study completion, an average of 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Completion of a qualitative interview discussing what patients' perceptions of the decision-making process are when choosing between colonic investigations
Time Frame: Through study completion, an average of 6 months
We will invite patients to undergo qualitative telephone interviews to establish their perceptions of the decision making process when choosing between colonic investigations.
Through study completion, an average of 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Aberdeen

Collaborators

NHS Highland

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 19, 2022

Primary Completion (Actual)

August 1, 2022

Study Completion (Actual)

January 11, 2024

Study Registration Dates

First Submitted

April 11, 2022

First Submitted That Met QC Criteria

May 20, 2022

First Posted (Actual)

May 26, 2022

Study Record Updates

Last Update Posted (Actual)

May 11, 2026

Last Update Submitted That Met QC Criteria

May 6, 2026

Last Verified

January 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2-014-22

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

This is a qualitative interview study so individual data will not be available to share

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colonic Disease

Clinical Trials on Interview

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burundi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe